Novel noncanonical splice site variant causes mild CHD7 ‐related disorder with variable intrafamilial expressivity
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63122 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Felix Boschann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Uni…. Hauptthemen laut MEDLINE: CHARGE Syndrome, Cleft Lip, Cleft Palate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical School - Charité - University Medicine Berlin.
Abstract (Originalsprache)
The clinical diagnosis criteria for CHARGE syndrome have been revised several times in the last 25 years. Variable expressivity and reduced penetrance are known, particularly in mild and familial cases. Therefore, it has been proposed to include the detection of a pathogenic CHD7 variant as a major diagnostic criterion. However, intronic variants not located at the canonical splice site are still underrepresented in mutation databases, often because functional analysis is not performed in the diagnostic setting. Here, we report a two‐generation family that did not meet the criteria for CHARGE syndrome, until the molecular findings were taken into account. By exome sequencing, we detected an intronic variant in a male individual, who presented with unilateral external ear malformation, bilateral semicircular canal aplasia, polydactyly, vertebral body fusion and a heart defect. The variant was inherited by his mother, who also had bilateral semicircular canal aplasia additionally to unilateral sensorineural hearing impairment, unilateral mandibular palpebral synkinesia, orofacial cleft, and dysphagia. Using RNA studies, we were able to demonstrate that aberrant splicing occurs at an upstream cryptic splice acceptor site, resulting in a frameshift and premature stop of translation. Our data show causality of the noncanonical intronic CHD7 variant and end the diagnostic odyssey of this unsolved phenotype of the family.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.
- Department of Otorhinolaryngology, Helios Hospital Berlin-Buch, Berlin, Germany.
- Labor Berlin Charité Vivantes GmbH-Corporate Member of Institute for Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Felix Boschann, Denise Horn
Förderung
- Medical School - Charité - University Medicine Berlin
Zitieren
APA
Boschann, F., Kosmehl, S., Bloching, M., Grünhagen, J., Hildebrand, G., Horn, D., & Lyutenski, S. (2023). Novel noncanonical splice site variant causes mild CHD7 ‐related disorder with variable intrafamilial expressivity. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63122
Vancouver
Boschann F, Kosmehl S, Bloching M, Grünhagen J, Hildebrand G, Horn D, et al. Novel noncanonical splice site variant causes mild CHD7 ‐related disorder with variable intrafamilial expressivity. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63122
BibTeX
@article{Boschann2023,
author = {Boschann, Felix and Kosmehl, Sabine and Bloching, Marc and Grünhagen, Johannes and Hildebrand, Gabriele and Horn, Denise and Lyutenski, Stefan},
title = {Novel noncanonical splice site variant causes mild CHD7 ‐related disorder with variable intrafamilial expressivity},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63122}
}
EUVIMED